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iso-butanol fraction with potent
biological activities
Christelle Joubouhi1, Jean-de-Dieu Tamokou2*, David Ngnokam1*, Laurence Voutquenne-Nazabadioko3
and Jules-Roger Kuiate2
Abstract
Background: The continuous emergence of multi-drug-resistant bacteria drastically reduces the efficacy of antibiotic
armory and, consequently, increases the frequency of therapeutic failure. The discovery of new antibacterial drugs is an
urgent need. The present study reports the antibacterial and antioxidant activities of the methanol extract, fractions
and iridoids from Canthium subcordatum, a plant traditionally used as antidiabetic, anti-inflammatory, and antimicrobial.
Methods: Broth microdilution assay was used to determine minimum inhibitory concentrations (MICs) and minimum
bactericidal concentrations (MBCs) of extracts and iridoids against Staphylococcus aureus, Vibrio cholerae and Shigella
flexneri. Antioxidant activity was evaluated using 1,1-diphenyl-2-picrylhydrazyl (DPPH) and gallic acid equivalent
antioxidant capacity (GAEAC) assays. The samples were also tested for their cytotoxicity against human red blood
cells (RBC).
Results: The methanol extract, hexane, ethyl acetate and iso-butanol fractions from C. subcordatum fruits
displayed different degrees of antioxidant (EC50 = 62.83–70.17 μg/ml; GAEAC = 45.63–58.23 μg/ml) and antibacterial
(MIC = 128–512 μg/ml) activities. Canthiumoside 1(1) and linearin (7) were the most active antioxidant
(EC50 = 1.12–2.03 μg/ml; GAEAC = 79.82–92.35 μg/ml) and antibacterial (MIC = 8–64 μg/ml) compounds while
the most sensitive bacterium was Staphylococcus aureus. The tested samples were non-toxic to normal cells.
Conclusion: Our results demonstrated that compounds 1 and 7 were potent antibacterial agents and DPPH/ABTS·+
radical scavengers, so they warrant further investigation.
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Background
The uses of plants in the indigenous cultures of developing
countries are numerous and diverse. For many people, the
high cost of imported conventional drugs and/or inaccessi-
bility to western health care facilities has led to overreliance
on traditional medicine since it is affordable and available
to rural people. On the other hand, even when western
health facilities are available, traditional medicine is viewed
as an efficient and an acceptable system from a cultural
perspective [1, 2]. Oxidative stress and diarrheal diseases
are among some of the indications treated using traditional
remedies in Cameroon. Diarrheal disease is a leading cause
of child mortality and morbidity in the world due to vari-
ous factors such as the HIV/AIDS pandemic, poor hygiene,
overcrowding and resistance to conventional antibacterials
while oxidative stress can lead to many illnesses including
cardiovascular diseases, diabetes, inflammation, degenera-
tive diseases, cancer, anemia, and ischemia [3]. Among the
diarrheal diseases, cholera is a serious epidemic disease
caused by the gram-negative bacterium Vibrio cholerae [4].
Vibrio cholerae, serotypes O1 and O139 has ability to
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determinant of virulence for cholera. There is a consen-
sus among the scientific community that plant derived
products have been playing a dominant role in the
discovery of leads for the development of drugs for the
treatment of human diseases [3]. Canthium subcorda-
tum (formely Psydrax subcordata) belonging to Rubiaceae
family is a tree which grows in central and western Africa
and reaches a height of more than 10 m [5]. Its roots,
leaves and stem bark are used for medicinal purposes [6].
Alcoholic extracts of the stem bark have potential antidia-
betic properties [6] and roots were used to treat malaria
fever, inflammation and cardiovascular disease [7]. Pet-
roleum ether and dichloromethane extracts of C. sub-
cordatum have shown anti-inflammatory activity in
COX-1 and COX-2 assays [8]. Previous phytochemical
works on this plant species and other Canthium species
revealed the presence of iridoids [8–10], iridoid pep-
tidic alkaloids [11, 12], flavonoids [10], terpenoids and
miscellaneous [12, 13]. However, it is not yet known
which of the phytoconstituents is responsible of the
antimicrobial effect of this plant, when it is used to cure
infectious diseases and oxidative stress conditions.
Therefore, the present study reports the antibacterial




The fruits of Canthium subcordatum DC (syn. Psydrax
subcordata DC Bridson) were collected in Foto village
(Menoua Division, Western region of Cameroon), in
April 2012. Authentication was performed by Victor
Nana, a Botanist of the Cameroon National Herbarium,
Yaoundé, where a voucher specimen (N° 19579/SRF/CAM)
has been deposited.
Experimental
The melting point, optical rotation, IR, 1H NMR, 13C
NMR, COSY, NOESY, HSQC, HMBC and HR-TOFESIMS
experiments were performed as previously described [10].
Extraction and isolation
The iso-butanol, ethyl acetate and hexane fractions as
well as the isolated compounds were obtained as pre-
viously described [10]. Briefly, the dried fruits of C.
subcordatum (3.50 kg) were extracted with MeOH,
and the resulting crude extract was suspended in
water and successively extracted with n-hexane, ethyl
acetate and iso-butanol to yield hexane, ethyl acetate and
iso-butanol fractions. The hexane and iso-butanol-solute
fractions were further fractionated and purified over silica
gel column chromatography to yield compounds 11–12
and 1–10 respectively [10]. None compound has been iso-
lated after the fractionation of the ethyl acetate fraction.
Structure elucidation by spectroscopy techniques showed
that they are canthiumosides 1–4 and 5a (1–4, 5a),
shanzhigenin methyl ester (6) and 1-epishanzhigenin
methyl ester (6’), linearin (7) and 1-epilinearin (7’),
mussaenoside (8), shanzhiside methyl ester (9), 3’,4’,7-
trihydroxyflavone (10), betulinic acid (11), and oleano-
lic acid (12) (Fig. 1).
Antibacterial assay
Microorganisms
A total of six bacterial strains were tested for their sus-
ceptibility to compounds and these strains were taken
from our laboratory collection (kindly provided by Dr.
T. Ramamurthy, NICED, Kolkata). Among the clinical
strains of Vibrio cholerae used in this study, strains NB2
and SG24(1) belonged to O1 and O139 serotypes, re-
spectively. These strains were able to produce cholera
toxin and hemolysin. The other strains used in this study
were V. cholerae non-O1, non-O139 (strains CO6 and
PC2); and Shigella flexneri SDINT. The V. cholerae
non-O1 and non-O139 strains, were positive for
hemolysin production but negative for cholera toxin
production. The strains of V. cholerae and S. flexneri
included in the present study were MDR clinical iso-
lates and these were resistant to commonly used
drugs such as ampicillin, streptomycin, tetracycline,
nalidixic acid, furazolidone, co-trimoxazole, etc. A ref-
erence strain, Staphylococcus aureus ATCC 25923,
was used for quality control. The bacterial strains
were maintained on agar slant at 4 °C and subcul-
tured on a fresh appropriate agar plates 24 h prior to
any antibacterial test. The Mueller Hinton Agar (MHA)
was used for the activation of bacteria. The Mueller
Hinton Broth (MHB) and nutrient agar (Hi-Media)
were used for the MIC and MBC determinations
respectively.
Determination of minimum inhibitory concentration (MIC)
and minimum bactericidal concentration (MBC)
MIC values were determined by a broth micro-dilution
method as described earlier [14] with slight modifications.
Each test sample was dissolved in dimethylsulfoxide
(DMSO) and the solution was then added to Mueller
Hinton Broth (MHB) to give a final concentration of
1024 μg/ml. This was serially diluted twofold to obtain a
concentration range of 0.50–1024 μg/ml. Then,
100 μl of each concentration was added in each well
(96-well microplate) containing 95 μl of MHB and
5 μl of inoculums (at 1.5 × 106 CFU/ml) for final con-
centrations varying from 0.25–512 μg/ml. Dilutions of
Ciprofloxacin and Ampicillin (256 – 0.125 μg/ml)
served as positive controls, while broth with 5 μL of
DMSO was used as negative control. The plates were
covered with sterile lids, then the contents of each well
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were mixed using a shaker and incubated at 35 °C for
24 h. The MIC values of samples were determined by
adding 50 μl of a 0.20 mg/ml p-iodonitrotetrazolium
violet solution followed by incubation at 35 °C for
30 min. MIC values were defined as the lowest sample
concentrations that prevented this change in color in-
dicating an inhibition of visible growth. Viable micro-
organisms reduced the yellow dye to a pink color. For
the determination of minimum bactericidal concentra-
tion (MBC) values, a portion of liquid (5 μl) from
each well that showed no growth of microorganism
was plated on Mueller Hinton Agar and incubated at
35 °C for 24 h. The lowest concentrations that yielded no
growth after this subculturing were taken as the MBC
values [15]. All the analyses were carried out in triplicate.
Antioxidant assay
DPPH free radical scavenging assay
The free radical scavenging activity of extracts as well as
most of their isolated compounds was performed according
Fig. 1 Chemical structures of the isolated compounds (1–12). 1: canthiumoside 1; 2: canthiumoside 2; 3: canthiumoside 3; 4: canthiumoside 4;
5: canthiumoside 5; 5a: canthiumoside 5a; 6: shanzhigenin methyl ester; 6’: 1-epishanzhigenin methyl ester; 7: linearin; 7’: 1-epilinearin; 8: mussaenoside;
9: shanzhiside methyl ester; 10: 3’,4’,7- trihydroxyflavone; 11: betulinic acid; 12: oleanolic acid
Joubouhi et al. BMC Complementary and Alternative Medicine  (2017) 17:17 Page 3 of 8
to Brand-Williams et al. [16] with slight modifications.
Briefly, different concentrations (10 to 2000 μg/ml)
of extracts/compounds and vitamin C (positive con-
trol) were thoroughly mixed with 3 ml of methanolic
DPPH solution (20 mg/l) in test-tubes and the result-
ing solution was kept standing for 30 min at room
temperature before the optical density (OD) was mea-
sured at 517 nm. The percentage radical scavenging
activity was calculated from the following formula: %
scavenging [DPPH] = [(A0–A1)/A0] × 100 [16]. Where
A0 was the absorbance of the negative control
(methanolic DPPH solution) and A1 was the absorb-
ance in the presence of the samples. IC50 value was
determined from the graph obtained using standard
vitamin C by using the “y = mx + c” formula from the
slope of the graph. All the analyses were carried out
in triplicate.
Gallic acid equivalent antioxidant capacity (GAEAC) assay
The GAEAC test was done as previously described [17]
with slight modifications. In a quartz cuvette, to 950 μl
acetate buffer (pH =5.0, 100 mM), the following were
added: 20 μl laccase (1 mM stock solution), 20 μl test
sample, 10 μl ABTS (2,2’-azinobis(3-ethylbenzothiazo-
line-6-sulfonic acid) (74 mM stock solution). The laccase
were purified from Sclerotinia sclerotiorum according
to the protocol described [18]. The sample concentra-
tions in the assay mixture were 800, 400, 200, 100,
10 μg/ml for the extracts and 200, 100, 50, 25,
125.5 μg/ml for the isolated compounds. The content
of the generated ABTS●+ radical was measured at
420 nm after 240 s reaction time and was converted
to gallic acid equivalents by the use of a calibration
curve (Pearson’s correlation coefficient: r = 0.996)
constructed with 0, 4, 10, 14, 28, 56, 84 μM gallic
acid standards rather than Trolox. Experiments were
done in triplicate.
Hemolytic assay
Hemolysis test was performed to determine cellular tox-
icity of the compounds as previously described [19].
Whole blood (10 ml) from a healthy man was col-
lected into a conical tube containing heparin as an
anticoagulant (blood group O was used). Extracts (at
concentrations ranging from 32 to 2048 μg/ml) and
pure compounds (16 to 256 μg/ml), were incubated
with an equal volume of 1% human red blood cells in
phosphate buffered saline (10 mM PBS, pH 7.4) at
37 °C for 1 h. 1% human red blood cells in buffer
was used as a non-hemolytic control whereas buffer
containing 1% Triton X-100 and 1% human red blood
cells served as a 100% hemolytic control. Cell lysis was
monitored by measuring the release of hemoglobin at
540 nm. The assay was repeated thrice. Percent hemolysis
was calculated as follows:
" 
A595 of sample treated with compound




A595 of sample treated with Triton X−100
–A595 of sample treated with buffer
!#
Statistical analysis
Data were analyzed by one-way analysis of variance
followed by Waller-Duncan Post Hoc test. The experi-
mental results were expressed as the mean ± Standard
Deviation (SD). Differences between groups were con-
sidered significant when p <0.05. All analyses were per-
formed using the Statistical Package for Social Sciences
(SPSS, version 12.0) software.
Results and discussion
Antibacterial activity
In the present work, the extracts as well as 12 compounds
isolated from the fruits of C. subcordatum were tested for
their antibacterial activities against Vibrio cholerae, Shi-
gella flexneri and Staphylococcus aureus (Table 1). The
MIC results indicated that the MeOH extract, n-BuOH
and EtOAc fractions as well as compounds 1, 2, 5a and
6–9 inhibited the growth of all tested bacterial species.
Hexane fraction and compound 3 showed selective activi-
ties, their inhibitory effects being noted on 5 of the 6
(83.33%) tested organisms. The lowest MIC values for the
extracts (128 μg/ml) and compounds (8 μg/ml) were re-
corded on S. aureus. The most active extract was the
EtOAc extract (MIC = 128–512 μg/ml) while compounds
1 (MIC = 32–64 μg/ml) and 7 (MIC = 8–64 μg/ml) were
the most active compounds. Cut-off points for antimicro-
bial activities were defined as follows: (i) For crude
extracts: significant activity (MIC < 100 μg/ml), moder-
ate activity (100 <MIC ≤ 625 μg/ml) or weak activity
(MIC > 625 μg/ml); (ii) For pure compounds: significant
activity (MIC <10 μg/mL), moderate activity (10 <MIC ≤
100 μg/ml), and low activity (MIC > 100 μg/ml) [20, 21].
Hence, the activity recorded herein for the extracts
(128 <MIC ≤ 512 μg/ml) and compounds 1 and 7 (10 <
MIC ≤ 100 μg/ml) is moderate whereas that of com-
pounds 2, 3, 5a, 6, 8 and 9 (MIC > 100 μg/ml) is low.
The lowest MIC value of 8 μg/ml was recorded with
compound 7 on Staphylococcus aureus, highlighting
some medicinal potential for this compound, as the
activity on S. aureus was equal to that of ampicillin. S.
aureus is a major cause of community and hospital-
associated infection with an estimated mortality of
around 7–10% [15, 22]. Moreover, about 2% of patients
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Table 1 Antibacterial activity (MIC and MBC in μg/ml) of extracts, isolated compounds and reference antibacterial drugs












MeOH extract MIC 512 256 512 512 256 128
MBC 512 256 512 512 256 256
MBC/MIC 1 1 1 1 1 2
n-BuOH extract MIC 512 512 512 512 256 128
MBC >512 512 512 >512 512 128
MBC/MIC / 1 1 / 2 1
EtOAc extract MIC 512 128 256 512 256 128
MBC 512 256 512 512 512 128
MBC/MIC 1 2 2 1 2 1
Hexane extract MIC >512 512 512 512 256 256
MBC / >512 >512 >512 >512 >512
MBC/MIC / / / / / /
1 MIC 64 64 64 64 32 32
MBC 128 64 64 64 64 32
MBC/MIC 2 1 1 1 2 1
2 MIC 256 128 128 256 128 64
MBC >256 256 128 256 256 64
MBC/MIC / 2 1 1 2 1
3 MIC >256 128 256 256 256 256
MBC / 256 256 >256 >256 >256
MBC/MIC / 2 1 / / /
5a MIC 256 128 128 128 128 128
MBC >256 256 128 256 128 128
MBC/MIC / 2 1 2 1 1
6 MIC 128 256 256 128 32 32
MBC 256 256 256 256 64 64
MBC/MIC 2 1 1 2 2 2
7 MIC 32 64 32 32 16 8
MBC 64 128 32 32 16 8
MBC/MIC 2 2 1 1 1 1
8 MIC 256 256 128 128 128 64
MBC >256 256 >256 256 256 128
MBC/MIC / 1 / 2 2 2
9 MIC 128 128 128 256 128 128
MBC 128 >256 128 256 256 256
MBC/MIC 1 / 1 1 2 2
Ampicillin MIC 16 16 >512 >512 >512 8
MBC 16 16 >512 >512 >512 8
MBC/MIC 1 1 / / / 1
Ciprofloxacin MIC 8 8 16 16 16 2
MBC 8 8 16 16 16 2
MBC/MIC 1 1 1 1 1 1
/ not determined, MIC minimum inhibitory concentration, MBC minimum bactericidal concentration
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in Cameroon are infected by Staphylococcus spp [14].
Each year, some 500,000 patients in American hospitals
contract a staphylococcal infection [15, 22]. Such findings
stress the importance of finding an antibiotic against
which Staphylococcus aureus is sensitive. It can also be
noted that the reference antibiotics were in most of the
case more active than all studied samples, except on
Vibrio cholerae NB2, Vibrio cholerae PC2 and Shigella
flexneri where ampicillin was not active. However, these
bacterial strains were found to be sensitive to most of the
tested samples, suggesting that their administration may
represent an alternative treatment against the V. cholerae,
the causative agent of cholera and S. flexneri, the causative
agent of shigellosis. Taking into account the medical im-
portance of the tested bacteria, this result can be consid-
ered as promising in the perspective of new antibacterial
drugs development. Although iridoids (sanshiside methyl
ester, sanshiside-D, mussaein, verbascoside, plumieride,
protoplumericin A, plumieride acid, plumericin and iso-
plumericin) have been reported to possess antiviral, anti-
microbial, anticancer and antioxidant properties [23–28],
this study report for the first time the antibacterial activity
of iridoids on MDR clinical multi-drug resistant (MDR)
pathogenic bacteria.
The results of Table 1 also showed detectable MBC
values for most of the studied samples on the tested bac-
terial strains. When analysing carefully the MIC and
MBC results for the extracts and compounds, it can be
noted that MBC/MIC ratios lower than 4 were obtained
with these samples on most of the tested microbial spe-
cies, suggesting that a bactericidal effect could be expected
[29, 30].
Antioxidant activity
Plant based antioxidant compounds [31, 32] play a
defensive role by preventing the generation of free radi-
cals and hence are extremely beneficial to alleviate the
diseases caused by oxidative stress such as cardiovascular
diseases, diabetes, inflammation, degenerative diseases,
cancer, anemia, and ischemia [33, 34]. In this study, free
radical scavenging capacities were measured using
DPPH radical and ABTS radical cation. The results are
expressed as gallic acid equivalent antioxidant capacity
of tested samples (Figs. 2 and 3) and as equivalent con-
centrations of test samples scavenging 50% of DPPH
radical (Fig. 3). Compounds 1 (EC50 = 2.03 μg/ml;
GAEAC = 79.82 μg/ml) and 7 (EC50 = 1.12 μg/ml;
GAEAC = 92.35 μg/ml) exerted the greatest activity
Fig. 2 Gallic acid equivalent antioxidant capacity (GEAC; μg/ml) of tested samples. Bars represent the mean ± SD of three independent experiments
carried out in triplicate. Letters a-i indicate significant differences between samples according to one way ANOVA and Waller Duncan test; p < 0.05.
1: canthiumoside 1; 2: canthiumoside 2; 3: canthiumoside 3; 4: canthiumoside 4; 5a: canthiumoside 5a; 6: shanzhigenin methyl ester; 7: linearin;
7’: 1-epilinearin; 8: mussaenoside; 9: shanzhiside methyl ester
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whereas compound 4 (EC50 = 178.57 μg/ml; GAEAC =
22.63 μg/ml) displayed the lowest antioxidant activity
in both assays (p < 0.05); suggesting that the ability of
these samples to scavenge DPPH could also reflect their
ability to inhibit the formation of ABTS+. Apart from
compounds 1 and 7, the EC50 value of vitamin C is lower
than those of the other tested samples, showing that these
samples are less active compared with vitamin C. How-
ever, the EC50 value of compound 7 (EC50 = 1.12 μg/ml) is
lower than that of standard vitamin C (EC50 = 1.74 μg/ml),
clearly indicating that this compound is more potent
than vitamin C in scavenging free radicals in vitro
(Fig. 3). Moreover, the EC50 value of compound 1
(EC50 = 2.03 μg/ml) is comparable to that of vitamin C
(EC50 = 1.74 μg/ml). In all, the DPPH and ABTS scaven-
ging activities in this study indicated that compounds 1
and 7 belonging to iridoids were potent antioxidants. Pre-
vious studies reported the antioxidant activities of some
iridoids from plant origin [35–37]. Hence, the antioxidant
activity of extracts in this study may be due to the pres-
ence of iridoids and phenolic compounds that are cap-
able of donating hydrogen to a free radical in order to
remove odd electron, which is responsible for the radi-
cal’s reactivity [28, 38].
Hemolytic activity
In this study, none of the tested samples showed
hemolytic activities against human red blood cells at
concentrations up to 512 μg/ml for the extracts and
256 μg/ml for pure compounds (results not shown) indi-
cating that it is non-toxic to normal cells.
Conclusion
Our results demonstrated that compounds 1 and 7 under
investigation were potent antibacterials and DPPH/ABTS·+
radical scavengers.
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